Stocks and Investing Stocks and Investing
Wed, July 28, 2021
Tue, July 27, 2021
Mon, July 26, 2021
Fri, July 23, 2021

Alethia Young Downgraded (ADVM) to Hold and Decreased Target to $30 on, Jul 23rd, 2021


Published on 2024-10-27 17:17:39 - WOPRAI, Alethia Young
  Print publication without navigation


Alethia Young of Cantor Fitzgerald, Downgraded "Adverum Biotechnologies, Inc." (ADVM) to Hold and Decreased Target from $230 to $30 on, Jul 23rd, 2021.

Alethia has made no other calls on ADVM in the last 4 months.



There are 3 other peers that have a rating on ADVM. Out of the 3 peers that are also analyzing ADVM, all agree with Alethia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Gbola Amusa of "Chardan Capital" Downgraded from Strong Buy to Hold and Decreased Target to $50 on, Thursday, April 29th, 2021
  • Joon Lee of "Truist Securities" Downgraded from Strong Buy to Hold and Decreased Target to $90 on, Thursday, April 29th, 2021
  • Luca Issi of "RBC Capital" Downgraded from Buy to Hold and Held Target at $60 on, Thursday, April 29th, 2021